Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 3,698 | 3,860 | 4,054 | 3,419 | 3,248 |
| Cost of Goods | 1,601 | 1,526 | 1,403 | 1,482 | 1,159 |
| Gross Profit | 2,097 | 2,334 | 2,651 | 1,937 | 2,089 |
| Operating Expenses | 5,503 | 5,505 | 4,990 | 6,204 | 6,382 |
| Operating Income | -2,805 | -2,645 | -1,936 | -3,785 | -4,134 |
| Other Income | -22 | 29 | 6 | 22 | -125 |
| Pre-tax Income | -2,827 | -2,616 | -1,930 | -3,763 | -4,259 |
| Net Income Continuous | -2,827 | -2,616 | -1,930 | -3,763 | -4,259 |
| Net Income | $-2,827 | $-2,616 | $-1,930 | $-3,763 | $-4,259 |
| EPS Basic Total Ops | 0.41 | -0.40 | -0.60 | -1.63 | -3.05 |
| EPS Basic Continuous Ops | 0.41 | -0.40 | -0.60 | -1.63 | -3.06 |
| EPS Diluted Total Ops | 0.41 | -0.40 | -0.60 | -1.63 | -3.05 |
| EPS Diluted Continuous Ops | 0.41 | -0.40 | -0.60 | -1.63 | -3.06 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.40 | -0.60 | N/A | N/A |
| EBITDA(a) | $-2,661 | $-2,499 | $-1,791 | $-3,639 | $-3,985 |